subscribeSubscribe
FDA fires off a warning on rare cases involving death, adverse liver events

FDA fires off a warning on rare cases involving death, adverse liver events
John Carroll ENDPTS
29 Aug 2019
Share Share
FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier & Vosevi

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier & Vosevi
FDA
29 Aug 2019
Share Share
FDA issues safety warning for newer hepatitis C drugs following patient deaths

FDA issues safety warning for newer hepatitis C drugs following patient deaths
Jacob Bell BIOPHARMADIVE
28 Aug 2019
Share Share
The Biopharmaceutical Cartel And High Drug Prices

The Biopharmaceutical Cartel And High Drug Prices
John LaMattina FORBES
10 Apr 2019
Share Share
Medicare Part D no match for runaway specialty drug costs: study

Medicare Part D no match for runaway specialty drug costs: study
Mark Miller REUTERS
07 Feb 2019
Share Share
Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues

Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues
Eric Palmer FIERCE PHARMA
04 Oct 2018
Share Share
Roche Hiked Cancer-Drug Prices Before Pledge to Keep Them Flat

Roche Hiked Cancer-Drug Prices Before Pledge to Keep Them Flat
Naomi Kresge BLOOMBERG
21 Jul 2018
Share Share
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze

Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze
Arlene Weintraub FIERCE PHARMA
20 Jul 2018
Share Share
In another win for Trump, Merck takes the drug pricing pledge

In another win for Trump, Merck takes the drug pricing pledge
John Carroll ENDPTS
20 Jul 2018
Share Share
Merck Is Lowering Drug Prices. There’s a Catch

Merck Is Lowering Drug Prices. There’s a Catch
Jessie Hellman THE HILL
20 Jul 2018
Share Share